Phase 1 Sarcomas Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1
Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas
Relapsed Sarcomas
Case Comprehensive Cancer Center24 enrolled1 locationNCT05210374
Recruiting
Phase 1
Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors
Solid TumorsSarcomas
Zai Lab (Shanghai) Co., Ltd.180 enrolled2 locationsNCT07374848
Recruiting
Phase 1
Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas
OsteosarcomaEwing SarcomaSarcomas
Children's Hospital of Philadelphia30 enrolled4 locationsNCT06156410
Recruiting
Phase 1
AOH1996 for the Treatment of Refractory Solid Tumors
Ovarian CancerRefractory Malignant Solid NeoplasmOsteosarcoma+2 more
City of Hope Medical Center92 enrolled2 locationsNCT05227326
Recruiting
Phase 1Phase 2
Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas
SarcomaSarcoma, SynovialSarcoma,Soft Tissue+6 more
Essen Biotech60 enrolled1 locationNCT07066982